Holoxan

Holoxan

ifosfamide

Manufacturer:

Transfarma Medica Indah

Marketer:

A Menarini
Concise Prescribing Info
Contents
Ifosfamide
Indications/Uses
Mammary carcinoma, cervical & ovarian carcinoma, bronchial carcinoma, soft tissue sarcoma, testicular tumors, malignant lymphoma, hypernephroma, pancreatic carcinoma, endometrial carcinoma.
Dosage/Direction for Use
Total: 250-300 mg/kg/course. Usual schedule: 50-60 mg/kg IV daily for 5 consecutive days.
Contraindications
Severe bone marrow depression; impaired renal function; bilateral urinary obstruction, acute infections, acute hemorrhagic cystitis. Pregnancy.
Special Precautions
Patients of reproductive age should use contraceptives during therapy & for the following 6 mth. Unilateral nephrectomies; brain metastases, infection, electrolyte imbalance.
Adverse Reactions
GI upsets; alopecia; reduction in blood count; cystitis; reversible encephalopathy. Immunosuppression. Occasionally, renal, hepatic & cardiac dysfunction in rare cases. Risk of secondary malignancies.
Drug Interactions
Neurotoxicity, hematotoxicity & nephrotoxicity may be increased by prior cisplatin therapy. Increased hypoglycemic effects w/ sulfonylureas. Increased bone marrow depression w/ allopurinol. Disturbances of anticoagulant control of warfarin.
MIMS Class
Cytotoxic Chemotherapy
ATC Classification
L01AA06 - ifosfamide ; Belongs to the class of alkylating agents, nitrogen mustard analogues. Used in the treatment of cancer.
Presentation/Packing
Form
Holoxan powd for inj 1 g
Packing/Price
(vial) 1's (Rp2,105,900/vial)
Form
Holoxan powd for inj 2 g
Packing/Price
1's (Rp3,400,500/vial)
Form
Holoxan powd for inj 500 mg
Packing/Price
1's (Rp1,094,860/vial)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in